“…Ultimately, previous modelling efforts here and from others ( Gonçalves, Bertrand, Ke, Comets, de Lamballerie, Malvy, Pizzorno, Terrier, Calatrava, Mentré, Smith, Perelson, Guedj, 2020 , Goyal, Cardozo-Ojeda, Schiffer, 2020 , Pinky, Dobrovolny, 2020 ) to represent SARS-CoV-2 could be further extended with control theoretical approaches such as optimal control and model predictive control to schedule drug candidate as well as immune modulators. Control theory in cooperation with Pharmacokinetic (PK)/Pharmacodynamic (PD) modelling have served for optimizing therapies in HIV and influenza infection ( Chang, Astolfi, 2008 , Hernandez-Mejia, Alanis, Hernandez-Gonzalez, Findeisen, Hernandez-vargas, 2019 , Rivadeneira, Caicedo, Ferramosca, Gonzalez, 2017 , Rivadeneira, Moog, Stan, Brunet, Raffi, Ferré, Costanza, Mhawej, Biafore, Ouattara, Ernst, Fonteneau, Xia, 2014 ).…”